Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.000
+0.280 (7.53%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $325.58 million as of June 26, 2026. Its market cap has increased by 450.73% in one year.
Market Cap
325.58M
Enterprise Value
266.82M
1-Year Change
450.73%
Ranking
Category
Stock Price
$4.00
Market Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $325.58M, an increase of 1,431.25%. That is a compound annual growth rate of 62.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 325.58M | 134.88% |
| Dec 31, 2025 | 138.62M | 268.99% |
| Dec 31, 2024 | 37.57M | -44.87% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rocket Pharmaceuticals | 354.88M |
| DiaMedica Therapeutics | 352.94M |
| Verastem | 332.16M |
| Galectin Therapeutics | 328.63M |
| Palisade Bio | 328.07M |
| Inhibikase Therapeutics | 325.51M |
| Abeona Therapeutics | 319.74M |
| Lineage Cell Therapeutics | 319.10M |